{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:32Z","timestamp":1761894812944,"version":"3.33.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1136\/ard.57.2.88","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T00:32:33Z","timestamp":1228523553000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study"],"prefix":"10.1016","volume":"57","author":[{"given":"Robin","family":"Munro","sequence":"first","affiliation":[]},{"given":"Rosie","family":"Hampson","sequence":"additional","affiliation":[]},{"given":"Anne","family":"McEntegart","sequence":"additional","affiliation":[]},{"given":"E Anne","family":"Thomson","sequence":"additional","affiliation":[]},{"given":"Rajan","family":"Madhok","sequence":"additional","affiliation":[]},{"given":"Hilary","family":"Capell","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/ard.57.2.88_bib1","first-page":"1023","article-title":"Back to the future: the pyramids of rheumatoid arthritis.","volume":"24","author":"Bensen","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib2","unstructured":"Kelly WN, Harris ED, Jr, Ruddy S, Sledge CB, eds (1985) Textbook of Rheumatology. (Saunders, Philadelphia), 2nd ed. p 979,."},{"key":"10.1136\/ard.57.2.88_bib3","first-page":"1290","article-title":"Clinical and health status measures over time: prognosis and outcome assessments in rheumatoid arthritis.","volume":"18","author":"Wolfe","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780360303","article-title":"The relative toxicity of disease-modifying anti-rheumatic drugs.","volume":"36","author":"Fries","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.2.88_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.54.12.944","article-title":"Early rheumatoid arthritis: time to aim for remission?","volume":"54","author":"Emery","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.57.2.88_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment \u201csecond-line\u201d anti rheumatic drugs: a randomised, controlled trial.","volume":"124","author":"van der Heijde","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.57.2.88_bib7","first-page":"1480","article-title":"The clinical value of the Stanford health assessment questionnaire functional disability index in patients with rheumatoid arthritis.","volume":"15","author":"Wolfe","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib8","first-page":"1307","article-title":"Mortality predictors among 263 patients with rheumatoid arthritis.","volume":"18","author":"Leigh","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.20.4.315","article-title":"Gold therapy in rheumatoid arthritis: final report of a multi-centre controlled trial.","volume":"20","year":"1961","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.57.2.88_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-80-1-21","article-title":"Gold salts in the treatment of rheumatoid arthritis: a double-blind study.","volume":"80","author":"Sigler","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.57.2.88_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/03009747709095448","article-title":"Effect of gold on progression of erosions in rheumatoid arthritis: better results with earlier treatment.","volume":"6","author":"Luukkainen","year":"1977","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib12","first-page":"175","article-title":"1958 revision of diagnostic criteria for rheumatoid arthritis.","volume":"9","author":"Ropes","year":"1958","journal-title":"Bull Rheum Dis"},{"key":"10.1136\/ard.57.2.88_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurements of patient outcome in arthritis.","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.2.88_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.1780290406","article-title":"The development of disability in rheumatoid arthritis.","volume":"29","author":"Sherrer","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.2.88_bib15","first-page":"1432","article-title":"More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability.","volume":"21","author":"Hakala","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib16","first-page":"1298","article-title":"The assessment and prediction of functional disability in rheumatoid arthritis.","volume":"18","author":"Wolfe","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.1780390502","article-title":"Guidelines for the management of rheumatoid arthritis.","volume":"39","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.2.88_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.47.8.648","article-title":"Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.","volume":"47","author":"Mottonen","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.57.2.88_bib19","first-page":"585","article-title":"Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease.","volume":"16","author":"Fuchs","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib20","first-page":"1792","article-title":"Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp\u2019s method (van der Heijde modification).","volume":"22","author":"van der Heijde","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib21","first-page":"1285","article-title":"Continuous progression of radiological destruction in seropositive rheumatoid arthritis.","volume":"24","author":"Kaarela","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/32.2.97","article-title":"Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic.","volume":"32","author":"Tunn","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.79","article-title":"Short-term outcomes in recent-onset rheumatoid arthritis.","volume":"34 (suppl 2)","author":"Young","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib24","first-page":"2208","article-title":"Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year follow up of a prospective double blind placebo controlled study.","volume":"22","author":"Egsmose","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib25","first-page":"1268","article-title":"Clinical and laboratory effects of prolonged therapy with sulphasalazine, gold or penicillamine: the effects of disease duration on treatment response.","volume":"17","author":"Situnayake","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","article-title":"The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis.","volume":"33","author":"Felson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.2.88_bib27","first-page":"1291","article-title":"Parenteral gold therapy for rheumatoid arthritis: a treatment whose time has gone.","volume":"16","author":"Epstein","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.2.88_bib28","first-page":"1326","article-title":"Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation.","volume":"23","author":"Harrison","year":"1996","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724415483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724415483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.57.2.88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:15:15Z","timestamp":1737548115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724415483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0003496724415483"],"URL":"https:\/\/doi.org\/10.1136\/ard.57.2.88","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1998,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.57.2.88","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}